Head to Head Comparison: Dynatronics (DYNT) & Boston Scientific (BSX)
Dynatronics (NASDAQ: DYNT) and Boston Scientific (NYSE:BSX) are both advanced medical equipment & technology – nec companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.
Valuation & Earnings
This table compares Dynatronics and Boston Scientific’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Dynatronics||$35.76 million||0.40||-$1.86 million||($1.12)||-2.59|
|Boston Scientific||$8.39 billion||4.11||$347.00 million||$0.61||41.15|
Boston Scientific has higher revenue and earnings than Dynatronics. Dynatronics is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
18.2% of Dynatronics shares are owned by institutional investors. Comparatively, 90.4% of Boston Scientific shares are owned by institutional investors. 51.8% of Dynatronics shares are owned by company insiders. Comparatively, 0.7% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This is a breakdown of current recommendations and price targets for Dynatronics and Boston Scientific, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Boston Scientific has a consensus price target of $30.90, suggesting a potential upside of 23.11%. Given Boston Scientific’s higher possible upside, analysts plainly believe Boston Scientific is more favorable than Dynatronics.
Volatility & Risk
Dynatronics has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.
This table compares Dynatronics and Boston Scientific’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Boston Scientific beats Dynatronics on 13 of the 14 factors compared between the two stocks.
Dynatronics Company Profile
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.
Boston Scientific Company Profile
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with Analyst Ratings Network's FREE daily email newsletter.